Understanding Transient Left Ventricular Ejection Fraction Reduction During Atrial Fibrillation With Artificial Intelligence
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.040641 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Neal Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine University of California San Francisco CA USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke Volume, Artificial Intelligence, Ventricular Function, Left. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) can cause a reduction in left ventricular ejection fraction (LVEF) that resolves rapidly upon restoration of sinus rhythm. We used artificial intelligence to understand (1) how often transient LVEF reduction during AF is from mismeasurement due to AF's beat‐to‐beat variability and (2) whether true transient AF‐LVEF reduction has prognostic significance.
Methods
In this observational study, we analyzed all patients at a large academic center with a transthoracic echocardiogram in AF and subsequent transthoracic echocardiogram in sinus rhythm within 90 days. We classified patients by their clinically reported LVEFs: no AF‐LVEF reduction, transient AF‐LVEF reduction that recovered after conversion to sinus rhythm, or persistent AF‐LVEF reduction that did not recover. We evaluated how automated multicycle AF‐LVEF measurement using a validated artificial intelligence algorithm affected AF‐LVEF and reclassified patients. We used Fine–Gray hazard modeling to analyze 1‐year heart failure hospitalization risk.
Results
In 810 patients (mean age 74.1 years, 34.3% female), 459 (56.7%) had no reduced AF‐LVEF, 71 (8.8%) had transient AF‐LVEF reduction, and 280 (34.6%) had persistent AF‐LVEF reduction. In the group with transient AF‐LVEF reduction, LVEF increased by 19.5% (95% CI, 12.0%–22.1%) upon conversion to sinus rhythm. AI reassessment increased AF‐LVEF by 8.2% (95% CI, 6.0%–10.4%), reclassifying 20 (28.2%) patients as no longer having reduced AF‐LVEF. The group with transient AF‐LVEF reduction, as determined by AI, had significantly higher 1‐year heart failure hospitalization risk (hazard ratio, 2.28 [95% CI, 1.23–4.21], P =0.003).
Conclusion
Artificial intelligence may decrease misdiagnosis of reduced LVEF during AF and more accurately identify true transient AF‐LVEF reduction, a potentially high‐risk phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine University of California San Francisco CA USA.
- Division of Cardiology San Francisco Veterans Affairs Medical Center San Francisco CA USA.
- Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.
ORCID-Profile: Neal Yuan, Alan C Kwan, Patrick Botting, Sanket S Dhruva, Robert J Siegel, David Ouyang
Förderung
- NHLBI NIH HHS
Zitieren
APA
Yuan, N., Hong, G. J., Vrudhula, A., Kwan, A. C., Duffy, G., Botting, P., Dhruva, S. S., Siegel, R. J., & Ouyang, D. (2025). Understanding Transient Left Ventricular Ejection Fraction Reduction During Atrial Fibrillation With Artificial Intelligence. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040641
Vancouver
Yuan N, Hong GJ, Vrudhula A, Kwan AC, Duffy G, Botting P, et al. Understanding Transient Left Ventricular Ejection Fraction Reduction During Atrial Fibrillation With Artificial Intelligence. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.040641
BibTeX
@article{Yuan2025,
author = {Yuan, Neal and Hong, Gloria J and Vrudhula, Amey and Kwan, Alan C and Duffy, Grant and Botting, Patrick and Dhruva, Sanket S and Siegel, Robert J and Ouyang, David},
title = {Understanding Transient Left Ventricular Ejection Fraction Reduction During Atrial Fibrillation With Artificial Intelligence},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.040641}
}
EUVIMED